TD Cowen Initiates Coverage On SI-BONE with Buy Rating, Announces Price Target of $21
1/27/2026
Impact: 70
Healthcare
TD Cowen analyst Mathew Blackman has initiated coverage on SI-BONE (NASDAQ: SIBN) with a Buy rating. The firm has set a price target of $21 for the stock.
AI summary, not financial advice
Share: